Menu
GeneBe

19-14151035-T-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_014921.5(ADGRL1):c.4248A>C(p.Glu1416Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000159 in 1,255,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000071 ( 0 hom., cov: 29)
Exomes 𝑓: 9.0e-7 ( 0 hom. )

Consequence

ADGRL1
NM_014921.5 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.600
Variant links:
Genes affected
ADGRL1 (HGNC:20973): (adhesion G protein-coupled receptor L1) This gene encodes a member of the latrophilin subfamily of G-protein coupled receptors (GPCR). Latrophilins may function in both cell adhesion and signal transduction. In experiments with non-human species, endogenous proteolytic cleavage within a cysteine-rich GPS (G-protein-coupled-receptor proteolysis site) domain resulted in two subunits (a large extracellular N-terminal cell adhesion subunit and a subunit with substantial similarity to the secretin/calcitonin family of GPCRs) being non-covalently bound at the cell membrane. Latrophilin-1 has been shown to recruit the neurotoxin from black widow spider venom, alpha-latrotoxin, to the synapse plasma membrane. Alternative splicing results in multiple variants encoding distinct isoforms.[provided by RefSeq, Oct 2008]
ADGRL1-AS1 (HGNC:55309): (ADGRL1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, ADGRL1
BP4
Computational evidence support a benign effect (MetaRNN=0.10820651).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ADGRL1NM_014921.5 linkuse as main transcriptc.4248A>C p.Glu1416Asp missense_variant 23/23 ENST00000361434.8
ADGRL1-AS1NR_045214.1 linkuse as main transcriptn.73-4117T>G intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ADGRL1ENST00000361434.8 linkuse as main transcriptc.4248A>C p.Glu1416Asp missense_variant 23/231 NM_014921.5 A1O94910-2
ADGRL1-AS1ENST00000588387.2 linkuse as main transcriptn.79-4117T>G intron_variant, non_coding_transcript_variant 1

Frequencies

GnomAD3 genomes
AF:
0.00000712
AC:
1
AN:
140456
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0000256
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
8.97e-7
AC:
1
AN:
1115134
Hom.:
0
Cov.:
39
AF XY:
0.00
AC XY:
0
AN XY:
542818
show subpopulations
Gnomad4 AFR exome
AF:
0.0000412
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000712
AC:
1
AN:
140456
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
68096
show subpopulations
Gnomad4 AFR
AF:
0.0000256
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 08, 2022The c.4263A>C (p.E1421D) alteration is located in exon 24 (coding exon 23) of the ADGRL1 gene. This alteration results from a A to C substitution at nucleotide position 4263, causing the glutamic acid (E) at amino acid position 1421 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.45
Cadd
Benign
20
Dann
Benign
0.80
DEOGEN2
Benign
0.10
T;.
Eigen
Benign
-0.20
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.63
T;T
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.69
T
MutationTaster
Benign
0.63
D;N
PrimateAI
Pathogenic
0.93
D
PROVEAN
Benign
1.5
N;N
REVEL
Benign
0.15
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.017
B;D
Vest4
0.21
MutPred
0.69
Loss of catalytic residue at E1421 (P = 0.0826);.;
MVP
0.11
MPC
0.32
ClinPred
0.64
D
GERP RS
3.9
Varity_R
0.093
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1273547234; hg19: chr19-14261847; API